The campaign, which will run for eleven weeks through 3 January 2021, is the 17th annual Thanks and Giving campaign at Domino’s
Domino’s Pizza, Inc., the largest pizza company in the world based on global retail sales, begins the annual St. Jude Thanks and Giving fundraising campaign to benefit St. Jude Children’s Research Hospital. The campaign, which will run for eleven weeks through 3 January 2021, is the 17th annual Thanks and Giving campaign at Domino’s.
To help the kids of St. Jude, customers can add a donation to their orders – on the phone, in stores or online. In addition to adding a whole dollar donation, customers can choose to round up their order total to donate the change to St. Jude.
“Franchise and corporate team members in stores across the country are looking forward to dedicating the rest of the year to raising funds for the kids at St. Jude Children’s Research Hospital,” said Ritch Allison, Domino’s CEO. “We are thrilled to join forces with our customers to support this incredible organisation in the fight against childhood cancer.”
In September, Domino’s announced its commitment to raise US$100m/£76m in ten years for St. Jude. In honor of the historic pledge, St. Jude will name its newest housing facility The Domino’s Village. The Domino’s Village will be a home away from home for patient families, offering a peaceful respite with living, dining and play spaces for patient family residents to enjoy.
St. Jude treats children with cancer, blood disorders and other life-threatening diseases across the US and around the world. Discoveries made at St. Jude are shared freely so every child saved at St. Jude means doctors and scientists can use that knowledge to save thousands more children around the world.
In addition to housing and food, St. Jude offers an on-site school and numerous other services for patients and their families. Families never receive a bill from St. Jude for treatment, travel, housing or food, because they believe all a parent should have to worry about is helping their child live.